Group 1 - The candidate, He Deming, has been nominated as an independent director for the fourth board of Tibet Yiming Xiya Pharmaceutical Technology Co., Ltd. and has confirmed understanding and agreement with the nomination [1] - The candidate declares that there are no relationships that could affect his independence and meets the qualifications required by relevant laws and regulations [1][2] - The candidate has passed the qualification review by the nomination committee of the company's third board and has no interests that could influence his independent performance [1][2] Group 2 - The candidate affirms compliance with the requirements of the Company Law of the People's Republic of China regarding eligibility to serve as a director [2] - The candidate has participated in training and obtained relevant certification recognized by the stock exchange [2] - The candidate confirms that serving as an independent director will not violate any relevant regulations, including those from the Central Commission for Discipline Inspection and the Ministry of Education [2][3] Group 3 - The candidate has no direct or indirect shareholding of more than 1% in the company or its major shareholders [5] - The candidate and immediate family members do not hold positions in the company or its subsidiaries [5][6] - The candidate has not been subject to any disqualifications or penalties by the China Securities Regulatory Commission or other regulatory bodies [7][8] Group 4 - The candidate commits to fulfilling the responsibilities of an independent director and ensuring that all statements and materials provided are true and complete [9][10] - The candidate will report any changes in eligibility to the board and will resign if any disqualifying conditions arise [9] - The candidate authorizes the company to disclose this declaration and related information to the Shenzhen Stock Exchange [10]
易明医药: 独立董事候选人声明与承诺-何德明